Profund Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-71
| Closed | -$244K | – | 1583 |
|
|
2018
Q2 | $244K | Buy |
+71
| New | +$244K | 0.01% | 1303 |
|
|
2017
Q2 | – | Sell |
-83
| Closed | -$209K | – | 1492 |
|
|
2017
Q1 | $209K | Sell |
83
-35
| -30% | -$88.1K | 0.01% | 1362 |
|
|
2016
Q4 | $265K | Buy |
+118
| New | +$265K | 0.01% | 1298 |
|
|
2016
Q1 | – | Sell |
-69
| Closed | -$356K | – | 1490 |
|
|
2015
Q4 | $356K | Buy |
+69
| New | +$356K | 0.02% | 839 |
|
|
2015
Q3 | – | Sell |
-76
| Closed | -$303K | – | 1394 |
|
|
2015
Q2 | $303K | Sell |
76
-16
| -17% | -$63.8K | 0.01% | 1113 |
|
|
2015
Q1 | $366K | Buy |
92
+32
| +53% | +$127K | 0.01% | 1117 |
|
|
2014
Q4 | $292K | Buy |
60
+7
| +13% | +$34.1K | 0.01% | 1144 |
|
|
2014
Q3 | $216K | Sell |
53
-230
| -81% | -$937K | 0.01% | 1187 |
|
|
2014
Q2 | $1.15M | Sell |
283
-50
| -15% | -$202K | 0.05% | 411 |
|
|
2014
Q1 | $1.51M | Buy |
333
+19
| +6% | +$86.3K | 0.07% | 270 |
|
|
2013
Q4 | $1.1M | Buy |
314
+74
| +31% | +$259K | 0.05% | 461 |
|
|
2013
Q3 | $986K | Buy |
240
+14
| +6% | +$57.5K | 0.05% | 446 |
|
|
2013
Q2 | $896K | Buy |
+226
| New | +$896K | 0.06% | 317 |
|